We demonstrated a progressive elevation of serum and salivary PDPN levels from controls to leukoplakia and overt OC, paralleling the shift from non-dysplastic to dysplastic and invasive phenotypes described in SRC- and RAS-driven oncogenic signaling. The gene discussed is PDPN; the disease is Oral leukoplakia.